UL Solutions Inc. (NYSE: ULS) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a global applied safety science and specialty business services company. On this page, Stock Titan connects those filings with AI‑powered summaries to help readers interpret the information more efficiently.
For UL Solutions, current reports on Form 8‑K provide insight into material events. Examples include disclosures about secondary public offerings of Class A common stock by a selling stockholder, where the company notes that it did not receive proceeds from the share sales, and a credit agreement establishing a senior unsecured multi‑currency revolving credit facility that includes a consolidated net leverage covenant and conditions on dividends. Other 8‑K filings discuss an expense reduction and restructuring plan focused on exiting certain non‑strategic lines of business and leadership changes among senior executives.
In addition to 8‑K reports, investors typically review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for details on UL Solutions’ testing, inspection and certification operations, software and advisory offerings, segment information and risk factors. While these specific forms are not reproduced here, they are accessible through the SEC’s EDGAR system and are summarized on Stock Titan when available.
Stock Titan’s tools surface key elements from UL Solutions’ filings, such as descriptions of credit facilities, restructuring plans, capital markets transactions and governance updates. The platform also highlights exhibits referenced in 8‑K filings, including underwriting agreements and legal opinions, so that users can understand how financing arrangements and other contracts relate to the company’s broader business. This page is designed to make it easier to follow UL Solutions’ regulatory disclosures without reading every document in full.
UL Solutions Inc. Senior VP & CAO Karen K. Pepping reported routine equity compensation activity. She exercised 725 restricted stock units, converting them into the same number of Class A Common Stock shares. In connection with this vesting, 271 shares were withheld to cover tax obligations at $91.60 per share.
After these transactions, she directly holds 9,078 shares of Class A Common Stock and 735 restricted stock units, including accrued dividend equivalent rights. The filing reflects compensation-related vesting and tax withholding rather than open-market buying or selling.
UL Solutions Inc. executive Lynn H. Hancock reported routine equity compensation activity involving Class A Common Stock and restricted stock units (RSUs). On May 1, 2026, Hancock exercised RSUs to acquire 1,293 shares of Class A Common Stock, then had 573 shares withheld at $91.60 per share to cover tax obligations. After these transactions, Hancock directly held 21,331 Class A shares. The filing also shows a small open-market purchase of 8 shares at $77.8191 on December 8, 2025 and a small acquisition of 9 shares under Rule 16a-6 on March 12, 2026. Footnotes explain that each RSU represents one Class A share, vesting in three equal annual installments beginning May 1, 2025, and that RSU totals include accrued dividend equivalent rights.
UL Solutions Inc. officer John A. Genovesi reported routine equity compensation activity. On May 1, 2026, he exercised restricted stock units to acquire 1,943 shares of Class A Common Stock, and 765 shares were disposed of to cover tax obligations. After these non‑open‑market transactions, he holds 30,935 Class A shares directly and 1,950 restricted stock units, including accrued dividend equivalents.
UL Solutions Inc. executive Scott D'Angelo, EVP, CLO & Corporate Secretary, reported compensation-related equity activity in Class A Common Stock on May 1, 2026. He exercised restricted stock units into 4,069 shares of Class A stock and had 1,193 shares withheld to cover tax obligations at $91.60 per share.
The filing shows no open-market purchases or sales; all dispositions are labeled as tax-withholding to satisfy liabilities arising from equity awards. Footnotes explain that each restricted stock unit converts into one share and that units vest in three equal installments beginning on May 1, 2025, including accrued dividend equivalent rights.
UL Solutions Inc. executive Linda S. Chapin reported routine equity compensation activity. On May 1, 2026, she exercised 1,456 restricted stock units, receiving the same number of shares of Class A Common Stock. To cover tax obligations, 611 shares of Class A Common Stock were disposed of through a tax-withholding transaction at $91.60 per share. After these transactions, Chapin directly holds 22,918 shares of Class A Common Stock and 1,464 restricted stock units, which continue to vest in three equal installments on the first, second and third anniversaries of May 1, 2024.
UL Solutions Inc. reported Q1 2026 revenue of $758 million, up from $705 million, driven by growth in Industrial and Consumer testing and ongoing certification services. Net income rose to $97 million from $71 million, with net margin improving to 12.8%.
Operating income increased to $138 million from $109 million as cost of revenue grew more slowly than sales and interest expense declined. Adjusted EBITDA reached $197 million and free cash flow was $150 million, supported by strong operating cash generation of $219 million.
The company is actively reshaping its portfolio. It closed the sale of its Employee Health and Safety software business for about $202 million in cash and expects a roughly $191 million pre-tax gain. It agreed to acquire Electrical and Electronics Testing LUX Holding SARL for enterprise value of €575 million plus daily ticking fees and to sell its ~28% stake in DQS Holding GmbH for about €105 million, both subject to customary conditions and approvals.
UL Solutions Inc. reported a strong first quarter of 2026, with revenue of $758 million, up 7.5% from 2025, driven by 5.7% organic growth led by the Industrial segment. Net income rose to $97 million, a 36.6% increase, and diluted EPS increased to $0.45 from $0.33.
Profitability improved meaningfully: Adjusted Net Income reached $107 million, Adjusted EBITDA was $197 million with a 26.0% margin, up 320 basis points. Free Cash Flow was $150 million on operating cash flow of $219 million, while the company reduced total debt to $360 million and ended the quarter with $258 million in cash.
The company is actively reshaping its portfolio. It sold its Employee Health and Safety software business for approximately $202 million in cash, agreed to acquire Eurofins’ E&E business valued at about €575 million, and agreed to sell its roughly 28% stake in DQS for about €105 million. For full-year 2026, management targets mid-single digit constant currency organic revenue growth, Adjusted EBITDA margin of about 27.0%, a roughly 26% effective tax rate and capital expenditures between 7% and 8% of revenue.
UL Solutions Inc. President and CEO Jennifer F. Scanlon reported open-market sales of a total of 12,500 shares of Class A Common Stock on May 1, 2026. The transactions were executed in two tranches at weighted average prices of $91.4294 and $92.0117 per share.
The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 9, 2025, indicating they were scheduled in advance. Scanlon continues to hold Class A Common Stock, including 89,285 shares held indirectly through a family trust.
Vanguard Capital Management reports beneficial ownership of 4,048,981 shares of UL Solutions Inc common stock. The filing shows this equals 5.23% of the class with 592,234 shares of sole voting power and 4,048,981 shares of sole dispositive power. The Schedule 13G lists Vanguard funds and affiliated business divisions as the sources of beneficial ownership.
UL Solutions Inc. is expanding through a major acquisition. The company agreed to buy Eurofins Scientific’s electrical and electronics testing business for approximately €575 million (about $670 million) in cash, using cash on hand, proceeds from a recent software divestiture, and its revolving credit facility.
The Eurofins E&E business is expected to generate about $200 million of revenue in 2026 and operate roughly 44 laboratories across EMEA, Asia-Pacific and the U.S. UL Solutions expects the deal, valued at about 14.5 times estimated 2026 EBITDA including cost synergies, to be accretive to Adjusted Diluted EPS in the first full year after closing.
The transaction is targeted to close in the fourth quarter of 2026, subject to numerous global regulatory approvals and other customary conditions. If required approvals are not obtained by October 13, 2027 or certain filing obligations are missed, UL’s subsidiary may owe a €34.5 million break fee to the seller.